To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
San Francisco-based Spruce Biosciences, a developer of novel therapies for rare endocrine disorders, has named Samir Gharib as chief financial officer and Dr. Dasharatha Reddy as vice president of pharmaceutical development and manufacturing.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Copyright PEI Media
Not for publication, email or dissemination